Response to the letter to editor regarding “piR-36249 and DHX36 together inhibit testicular cancer cells progression by upregulating OAS2”

Detalles Bibliográficos
Autores principales: Wang, Qianqian, Chen, Peize, Wang, Xiaorong, Song, Xiaoyuan, Sun, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477800/
https://www.ncbi.nlm.nih.gov/pubmed/37675270
http://dx.doi.org/10.1016/j.ncrna.2023.08.008
_version_ 1785101213340008448
author Wang, Qianqian
Chen, Peize
Wang, Xiaorong
Song, Xiaoyuan
Sun, Fei
author_facet Wang, Qianqian
Chen, Peize
Wang, Xiaorong
Song, Xiaoyuan
Sun, Fei
author_sort Wang, Qianqian
collection PubMed
description
format Online
Article
Text
id pubmed-10477800
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher KeAi Publishing
record_format MEDLINE/PubMed
spelling pubmed-104778002023-09-06 Response to the letter to editor regarding “piR-36249 and DHX36 together inhibit testicular cancer cells progression by upregulating OAS2” Wang, Qianqian Chen, Peize Wang, Xiaorong Song, Xiaoyuan Sun, Fei Noncoding RNA Res Letter to the Editor KeAi Publishing 2023-08-24 /pmc/articles/PMC10477800/ /pubmed/37675270 http://dx.doi.org/10.1016/j.ncrna.2023.08.008 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letter to the Editor
Wang, Qianqian
Chen, Peize
Wang, Xiaorong
Song, Xiaoyuan
Sun, Fei
Response to the letter to editor regarding “piR-36249 and DHX36 together inhibit testicular cancer cells progression by upregulating OAS2”
title Response to the letter to editor regarding “piR-36249 and DHX36 together inhibit testicular cancer cells progression by upregulating OAS2”
title_full Response to the letter to editor regarding “piR-36249 and DHX36 together inhibit testicular cancer cells progression by upregulating OAS2”
title_fullStr Response to the letter to editor regarding “piR-36249 and DHX36 together inhibit testicular cancer cells progression by upregulating OAS2”
title_full_unstemmed Response to the letter to editor regarding “piR-36249 and DHX36 together inhibit testicular cancer cells progression by upregulating OAS2”
title_short Response to the letter to editor regarding “piR-36249 and DHX36 together inhibit testicular cancer cells progression by upregulating OAS2”
title_sort response to the letter to editor regarding “pir-36249 and dhx36 together inhibit testicular cancer cells progression by upregulating oas2”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477800/
https://www.ncbi.nlm.nih.gov/pubmed/37675270
http://dx.doi.org/10.1016/j.ncrna.2023.08.008
work_keys_str_mv AT wangqianqian responsetothelettertoeditorregardingpir36249anddhx36togetherinhibittesticularcancercellsprogressionbyupregulatingoas2
AT chenpeize responsetothelettertoeditorregardingpir36249anddhx36togetherinhibittesticularcancercellsprogressionbyupregulatingoas2
AT wangxiaorong responsetothelettertoeditorregardingpir36249anddhx36togetherinhibittesticularcancercellsprogressionbyupregulatingoas2
AT songxiaoyuan responsetothelettertoeditorregardingpir36249anddhx36togetherinhibittesticularcancercellsprogressionbyupregulatingoas2
AT sunfei responsetothelettertoeditorregardingpir36249anddhx36togetherinhibittesticularcancercellsprogressionbyupregulatingoas2

Ejemplares similares